Tiantan Bio proposes director changes, governance updates at AGM

Beijing Tiantan Biological Products Corp (SSE:600161) is set to hold its 2024 Annual General Meeting (AGM) on May 20, 2025, seeking shareholder approval for several key resolutions. Among the key proposals is the nomination of Zhang Jieming and Wang Qi as new directors. The company also seeks approval to revise its Articles of Association and various corporate governance rules, including those related to shareholder meetings, board operations, and independent directors. The agenda includes a proposal to abolish the Supervisory Board and its associated rules.